These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15888706)

  • 41. [Implantable pacemaker-cardioverter-defibrillator. A cost-effective and life-prolonging treatment].
    Ohm OJ
    Tidsskr Nor Laegeforen; 1997 Apr; 117(9):1263-5. PubMed ID: 9182350
    [No Abstract]   [Full Text] [Related]  

  • 42. Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy.
    Kadish A; Mehra M
    Circulation; 2005 Jun; 111(24):3327-35. PubMed ID: 15967863
    [No Abstract]   [Full Text] [Related]  

  • 43. Cost advantage of different cardioverter-defibrillator devices.
    Veenhuyzen GD
    J Am Coll Cardiol; 2006 Jul; 48(2):418-9; author reply 419. PubMed ID: 16843205
    [No Abstract]   [Full Text] [Related]  

  • 44. Transvenous implantable cardioverter-defibrillator leads: the weakest link.
    Maisel WH
    Circulation; 2007 May; 115(19):2461-3. PubMed ID: 17502585
    [No Abstract]   [Full Text] [Related]  

  • 45. Medicare coverage of catheters.
    Muller N
    Ostomy Wound Manage; 2009 Mar; 55(3):10. PubMed ID: 19673059
    [No Abstract]   [Full Text] [Related]  

  • 46. The implantable cardiac defibrillator: is the glass half empty or half full?
    de Lissovoy G
    Med Care; 2007 May; 45(5):371-3. PubMed ID: 17446821
    [No Abstract]   [Full Text] [Related]  

  • 47. 2009: time sensitive healthcare issues await. SCHIP, Medicaid and Medicare payment reductions on lawmakers' to-do list for the new year.
    Ferman JH
    Healthc Exec; 2009; 24(1):54-5. PubMed ID: 19601415
    [No Abstract]   [Full Text] [Related]  

  • 48. [Implantable defibrillators. Good cost-effectiveness or supplementary expense to our hospitals?].
    Lévy S; Aliot E; Clémenty J; Kacet S; Coumel P
    Arch Mal Coeur Vaiss; 1999 Mar; 92(3):289-91. PubMed ID: 10221139
    [No Abstract]   [Full Text] [Related]  

  • 49. Cost effectiveness of the implantable cardioverter defibrillator.
    Roberts PR; Betts TR; Morgan JM
    Eur Heart J; 2000 May; 21(9):712-9. PubMed ID: 10739726
    [No Abstract]   [Full Text] [Related]  

  • 50. Implantable cardioverter-defibrillators.
    Patwala A; Schlosshan D; Williams SG
    N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15892193
    [No Abstract]   [Full Text] [Related]  

  • 51. The cost of implantable defibrillators: perceptions and reality.
    Camm J; Klein H; Nisam S
    Eur Heart J; 2007 Feb; 28(4):392-7. PubMed ID: 16887857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Current indications for cardioverter-defibrillator implant in patients with syncope].
    Santini M; Colivicchi F; Ammirati F; Ricci R
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):575-9. PubMed ID: 12497786
    [No Abstract]   [Full Text] [Related]  

  • 53. Who should be paying for vitamin D analogues--Medicare or the patients?
    Hall G
    Nephrol Nurs J; 2006; 33(3):345-6, 351. PubMed ID: 16859205
    [No Abstract]   [Full Text] [Related]  

  • 54. Indications to implantable cardioverter defibrillator in heart failure patients: a comment on the recently released ESC Guidelines on treatment and diagnosis of heart failure.
    Gasparini M; Breithardt G
    Eur Heart J; 2005 Nov; 26(22):2472-3; author reply 2473-4. PubMed ID: 16204261
    [No Abstract]   [Full Text] [Related]  

  • 55. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?
    Curtis AB
    J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250
    [No Abstract]   [Full Text] [Related]  

  • 56. Medicare spends billions on "low value" services, US study finds.
    McCarthy M
    BMJ; 2014 May; 348():g3333. PubMed ID: 25134149
    [No Abstract]   [Full Text] [Related]  

  • 57. Right ventricular anodal capture during left ventricular stimulation in CRT-implantable cardioverter defibrillators (ICD).
    van Gelder BM; Bracke FA; van der Voort PH; Meijer A
    Pacing Clin Electrophysiol; 2006 Mar; 29(3):337; author reply 337-8. PubMed ID: 16606407
    [No Abstract]   [Full Text] [Related]  

  • 58. The American health care system.
    Leeman CP
    N Engl J Med; 1999 Sep; 341(12):918; author reply 920. PubMed ID: 10498463
    [No Abstract]   [Full Text] [Related]  

  • 59. The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe?
    Meine M; Smith T; Hauer RN
    Europace; 2009 Jun; 11(6):689-91. PubMed ID: 19470592
    [No Abstract]   [Full Text] [Related]  

  • 60. Expansion of heart failure device therapy into a rural indigent population in Louisiana: potential economic and health policy implications.
    Hebert K; McKinnie J; Horswell R; Arcement L; Stevenson L
    J Card Fail; 2006 Dec; 12(9):689-93. PubMed ID: 17174229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.